Barriers to HIV Cure

被引:21
|
作者
Stein, J. [1 ]
Bonsmann, M. Storcksdieck Genannt [1 ]
Streeck, H. [1 ,2 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Inst HIV Res, Essen, Germany
[2] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA
关键词
cellular barriers; HIV; immunological barriers; SIMIAN IMMUNODEFICIENCY VIRUS; T FOLLICULAR HELPER; ACTIVE ANTIRETROVIRAL THERAPY; CENTRAL-NERVOUS-SYSTEM; INFECTED PATIENTS; POSTEXPOSURE PROPHYLAXIS; CONTROLLED-TRIAL; VIRAL RESERVOIR; IMMUNE FUNCTION; CELL DEPLETION;
D O I
10.1111/tan.12867
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since the beginning of the epidemic, more than 70 million people have been infected with human immunodeficiency virus (HIV) and about 38 million have died from acquired immune deficiency syndrome (AIDS)-related illnesses. While the discovery of highly active antiretroviral therapy (HAART) in the mid 90' s has saved millions of lives, a complete eradication of HIV is still not possible as HIV can persist for decades in a small reservoir of latently infected cells. Once reactivated, these latently infected cells can actively produce viral particles. Recent studies suggest that several sanctuaries exist within infected individuals where HIV can remain undetected by the immune system. These cellular, anatomical and microanatomical viral reservoirs represent a major obstacle for the eradication of HIV. Here we review recent findings on potential sanctuaries of HIV and address potential avenues to overcome these immunological barriers.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [41] CRISPR therapy towards an HIV cure
    Herrera-Carrillo, Elena
    Gao, Zongliang
    Berkhout, Ben
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 201 - 208
  • [42] Potential Strategies for an HIV Infection Cure
    Lafeuillade, Alain
    HIV CLINICAL TRIALS, 2011, 12 (03): : 121 - 130
  • [43] Advances in Developing CAR T-Cell Therapy for HIV Cure
    Qi, Jinxin
    Ding, Chengchao
    Jiang, Xian
    Gao, Yong
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [44] Barriers and levers to HIV post-exposure prophylaxis
    Charpentier, Nicolas
    Quatremere, Guillemette
    Mabire, Xavier
    Roduit, Sabrina
    Laguette, Vanessa
    Spittler, Didier
    Guillois, Elodie
    Martin, Cyril
    Castro, Daniela Rojas
    Preau, Marie
    SANTE PUBLIQUE, 2016, 28 (06): : 791 - 799
  • [45] Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
    Vieillard, Vincent
    Gharakhanian, Shahin
    Lucar, Olivier
    Katlama, Christine
    Launay, Odile
    Autran, Brigitte
    Fang, Raphael Ho Tsong
    Crouzet, Joel
    Murphy, Robert L.
    Debre, Patrice
    ONCOTARGET, 2016, 7 (25) : 38946 - 38958
  • [46] HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies
    Chan, Phillip
    Spudich, Serena
    CURRENT HIV/AIDS REPORTS, 2022, 19 (03) : 207 - 216
  • [47] Interests of the Non-Human Primate Models for HIV Cure Research
    Terrade, Gauthier
    Huot, Nicolas
    Petitdemange, Caroline
    Lazzerini, Marie
    Orta Resendiz, Aurelio
    Jacquelin, Beatrice
    Muller-Trutwin, Michaela
    VACCINES, 2021, 9 (09)
  • [48] How Might We Cure HIV?
    Margolis, David M.
    CURRENT INFECTIOUS DISEASE REPORTS, 2014, 16 (03)
  • [49] Modeling HIV persistence and cure studies
    Hill, Alison L.
    CURRENT OPINION IN HIV AND AIDS, 2018, 13 (05) : 428 - 434
  • [50] Cancer therapies in HIV cure research
    Rasmussen, Thomas A.
    Anderson, Jenny L.
    Wightman, Fiona
    Lewin, Sharon R.
    CURRENT OPINION IN HIV AND AIDS, 2017, 12 (01) : 96 - 104